Variant · Snv
FHL2 NM_001318895.3(FHL2):c.120C>T (p.Cys40=)
CI-VAR-00008765Explore in graph →p.Cys40=NM_001318895.3:c.120C>TClinVar 48320 rs11537578
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 48320 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Primary dilated cardiomyopathy; Thyroid cancer, nonmedullary, 1; Hepatocellular carcinoma; Lung cancer; Cervical cancer; Uterine corpus endometrial carcinoma; Ovarian serous cystadenocarcinoma; Clear cell carcinoma of kidney; Uterine carcinosarcoma | germline | 3 | Feb 02, 2026 | clinvar |